Health-related quality of life following hybrid minimally invasive versus open esophagectomy for patients with esophageal cancer, analysis of a multicenter, open-label, randomized phase III controlled trial: The MIRO trial

Annals of Surgery

Volumn 271, Issue 6, 2020, Pages 1023-1029

  Mariette, Christophe ^a,b,c,d   Markar, Sheraz ^e   Dabakuyo Yonli, Tienhan Sandrine ^f,g   Meunier, Bernard ^h   Pezet, Denis ⁱ   Collet, Denis ^j   D'Journo, Xavier Benoit ^k   Brigand, Cécile ^l   Perniceni, Thierry ^m   Carrere, Nicolas ⁿ   Mabrut, Jean Yves ^o   Msika, Simon ^p   Peschaud, Frédérique ^q   Prudhomme, Michel ^r   Bonnetain, Franck ^s   Piessen, Guillaume ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^d Methodology Clinical Research Platform   (France)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f CENTRE GEORGES FRANÇOIS LECLERC   (France)

^g National Clinical Research Platform for Quality of Life in Oncology   (France)

^h UNIVERSITÉ DE RENNES 1   (France)

ⁱ UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k AIX MARSEILLE UNIVERSITY   (France)

^l UNIVERSITÉ DE STRASBOURG   (France)

^m INSTITUT MUTUALISTE MONTSOURIS   (France)

ⁿ CANCER RESEARCH CENTER OF TOULOUSE   (France)

^o UNIVERSITÉ LYON 1   (France)

^p HÔPITAL LOUIS MOURIER   (France)

^q HÔPITAL AMBROISE PARÉ   (France)

^r NÎMES UNIVERSITY HOSPITAL   (France)

^s UNIVERSITY HOSPITAL OF BESANÇON   (France)

more..

Author keywords

esophageal cancer; health related quality of life; minimally invasive approach; surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CHEMORADIOTHERAPY; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE CORE 30; FEMALE; FOLLOW UP; GLOBAL HEALTH; HUMAN; HYBRID MINIMALLY INVASIVE ESOPHAGECTOMY; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY; NEOADJUVANT CHEMOTHERAPY; OPEN STUDY; OPEN SURGERY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SOCIAL INTERACTION; SOCIAL STATUS; TUMOR INVASION; ADOLESCENT; CLINICAL TRIAL; ESOPHAGUS TUMOR; MIDDLE AGED; POSTOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; PSYCHOLOGY; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; POSTOPERATIVE PERIOD; PROGNOSIS; QUALITY OF LIFE; TIME FACTORS; YOUNG ADULT;

EID: 85070588656     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000003559     Document Type: Article

References (25)

1. AA. Available at: http://www.hscic.gov.uk/og. Accessed November 25, 2016.
2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-2252.
3. Mariette C, Piessen G, Briez N, et al. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 2011;12:296-305.
4. Biere SS, Van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379: 1887-1892.
5. Briez N, Piessen G, Torres F, et al. Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg. 2012;99:1547-1553.
6. Van der Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14:210-218.
7. Lacey AM, Garcia-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359:2224-2229.
8. Kim W, Kim HH, Han SU, et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg. 2016;263:28-35.
9. Gujral S, Conroy T, Fleissner C, et al. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer. 2007;43:1564-1573.
10. Efficace R, Fayers P, Pusic A, et al. Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: a pooled analysis of 557 trials. Cancer. 2015;121:3335-3342.
11. Schandl A, Lagergren J, Johar A, et al. Health-related quality of life 10 years after oesophageal cancer surgery. Eur J Cancer. 2016;69:43-50.
12. Jacobs M, Macefield RC, Elbers RG, et al. Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery. Qual Life Res. 2014;23:1155-1176.
13. Andersson J, Angenete E, Gellerstedt M, et al. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial. Br J Surg. 2013;100:941-949.
14. Janson M, Lindholm E, Anderberg B, et al. Randomized trial of health-related quality of life after open and laparoscopic surgery for colon cancer. Surg Endosc. 2007;21:747-753.
15. Stucky CCH, Pockaj BA, Novotny PJ, et al. Long-term follow-up and individual item analysis of quality of life assessment related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011;18:2422-2431.
16. Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of life and late complications after minimally invasive compared to open esophagectomy: results a randomized trial. World J Surg. 2015;39:1986-1993.
17. Mariette C, Markar SR, Dabayuko-Yonli TS, et al. Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med. 2019;380:152-162.
18. Briez N, Piessen G, Bonnetain F, et al. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial-the MIRO trial. BMC Cancer. 2011;11:310.
19. AA. Available at: http://groups.eortc.be/qol/eortc-qlq-c30. Accessed April 5, 2019.
20. Blazeby JM, ConroyT,HammerlidE, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTCQLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39:1384-1394.
21. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-144.
22. Kauppila JH, Xie S, Johar A, et al. Meta-analysis of health-related quality of life after minimally invasive versus open oesophagectomy for oesophageal cancer. Br J Surg. 2017;104:1131-1140.
23. Derogar M, Lagergren P. Health-related quality of life among 5-year survivors of esophageal cancer surgery: a prospective population-based study. J Clin Oncol. 2012;30:413-418.
24. Derogar M, Orsini N, Sadr-Azodi O, et al. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol. 2012;30:1615-1619.
25. Metcalfe C, Avery K, Berrisford R, et al. Comparing open and minimally invasive surgical procedures for oesophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial. Health Technol Assess. 2016;20:1-68.